Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You are witnessing pure genius and brilliance by said controller...
I hear a penny knocking on the door. It's garbage and will remain so . Nothing can reverse this.
hopester
Tuesday, 08/14/18 12:29:20 PM
Re: None
0
Post # of 30179
I hear a penny knocking on the door. It's garbage and will remain so . Nothing can reverse this.
hopester
Monday, 07/23/18 02:36:33 PM
Re: joanne4trade post# 568
0
Post # of 572
"Analysts" had it as a STRONG BUY AT $55....with a target in the low 60's
So much for their analysis.
3 subjects...
Nothing better states the 'infancy' of the progress toward R18 general approval...
2020 is 20/20. NOTHING sooner. No Way.
What could be the problem with R18 and FDA large primate PIII study commencement?! Seemed to be on the fast track, but now seems significantly delayed... No evidence that it has started or even moved beyond 'discussions'... We want ANSWERS!!
For all we know, they could be hiding in a cave knowing they bet on r18 but now know dilution is inevitable and the death spiral has begun.
The Stock Has Been Under Control For A Very Long Time !
FDApproved
Monday, 05/22/17 04:05:18 PM
Re: None
0
Post # of 18695
I Told You ! The Stock Has Been Under Control For A Very Long Time !
I Cannot Wait Until They Get The Deal Done !!!!!!!!!!!!!!!!
When They Do, We Go Skyward ! BIGTIME !
BREAKING NEWS ! ZAMI RELEASED A VIDEO 1 HOUR AGO !
FDApproved
Thursday, 05/18/17 11:42:43 AM
Re: None
0
Post # of 18694
BREAKING NEWS ! ZAMI RELEASED A VIDEO 1 HOUR AGO !
https://twitter.com/Pluristem
Pluristem Does Not Need Any Cash !
FDApproved
Wednesday, 05/17/17 03:12:31 PM
Re: None
0
Post # of 18693
Pluristem Does Not Need Any Cash !
They Have Enough For At Least 1 Year ! Next Week, You Will Be Singing A Very Different Tune ! Fun To Watch The Non-Believers Squirm & Squawk ! The Controller Is Performing Flawlessly !
Yaky & Zami.. Gonna Hit A Grand Slammy In My Opinionammy !
Weeeeeeeeeeeeeeeeeeeee...What...........A...........Ride....!
Don't Forget To Vote By Next Wednesday ! :)
http://www.genengnews.com/gen-news-highlights/pluristem-buys-patents-covering-stem-cell-production-tool-for-2m/17851968
FDApproved
Wednesday, 05/17/17 03:12:31 PM
Re: None
0
Post # of 18693
Pluristem Does Not Need Any Cash !
They Have Enough For At Least 1 Year ! Next Week, You Will Be Singing A Very Different Tune ! Fun To Watch The Non-Believers Squirm & Squawk ! The Controller Is Performing Flawlessly !
Yaky & Zami.. Gonna Hit A Grand Slammy In My Opinionammy !
Weeeeeeeeeeeeeeeeeeeee...What...........A...........Ride....!
Don't Forget To Vote By Next Wednesday ! :)
http://www.genengnews.com/gen-news-highlights/pluristem-buys-patents-covering-stem-cell-production-tool-for-2m/17851968
"BOLD...YET ABSOLUTELY CORRECT !"
FDApproved
Wednesday, 05/10/17 11:04:28 AM
Re: None
0
Post # of 18692
BOLD...YET ABSOLUTELY CORRECT !
BEAUTIFUL BARDA CONTRACT COMING THIS SUMMER...THEN ISRAEL CONTRACT...THEN NATIONS X,Y,Z !!! GIDDY-UP !
"The Sosei & China Deals Are Still On,..."
FDApproved
Monday, 05/08/17 05:01:11 PM
Re: None
0
Post # of 18690
Synopsis Of The 10K !
Pluristem Has Over 28 Million In The Bank. The Sosei & China Deals Are Still On, They Have Until June 30,2017 To Close Both Deals.
"One Thing I Can Almost Guarantee Will Happen!"
FDApproved
Friday, 05/12/17 06:59:16 PM
Re: None
0
Post # of 18689
One Thing I Can Almost Guarantee Will Happen!
Pluristem Has Taken A Lot Of Heat For Taking Over 4 Years To Complete The 150 Patient (IC) Intermittent Claudication Trial. So Much So, Management Wisely Replaced Their Clinical Trial Manager Last Year. I Recall Yaky Saying About 2 Interviews Ago That This Global CLI Clinical Trial Is Going To Go FAST ! They Have Learned From Their Past Mistakes And Hired A Top Notch CRO To Move This Trial Along Quickly: Quote From Zami: "The CRO we chose has extensive experience working with leading pharmaceutical and biotech companies to successfully manage clinical trials. We are excited to move forward to bring clinical sites online and begin enrolling patients.”
The Medidata Cloud Contract Pluristem Signed Last August Will Be The Key Driver To A Much, Much Faster CLI Clinical Trial. I Believe It Was Soon After This Contract Was Announced That Yaky Said In An Interview That The Global CLI 40 Site Clinical Trial Will Go Very Fast. I Believe Yaky And Zami ! They Learned Big-Time From The IC Trial !
Pluristem Therapeutics Deploys Medidata's Cloud Technology
http://investor.mdsol.com/releasedetail.cfm?releaseid=982558
“If we can inject these cells after exposure to radiation, we will be able to keep the entire population alive,”
FDApproved
Monday, 05/08/17 07:21:26 AM
Re: None
0
Post # of 18687
Sitting on stage at The Jerusalem Post Annual Conference in New York on Sunday.
(He Is Here In The USA !) That's A Good Sign !
Innovator Yaky Yanay(innovative accountant) pulled a small glass vial out of his pocket – promising a solution to Iranian nuclear threats.
“I have the solution in my pocket,” said Yanay, CEO and president of Pluristem Therapeutics.
The Haifa-based company, which aims to create “the next generation of biological therapeutic products,” specializes in harnessing placental cells to treat a variety of diseases using a three-dimensional platform. For one such ailment that Pluristem is targeting, Acute Radiation Syndrome, the company is currently conducting dose evaluation studies with the US National Institutes of Health’s NIAID PLX-R18 cells – the same cells in Yanay’s glass vial.
“If we can inject these cells after exposure to radiation, we will be able to keep the entire population alive,” he said.
As Pluristem continues to delve into cell therapy research, the company is focusing on increasing longevity in the face of illnesses that today have no viable treatments. In addition, the company expressed hopes that the introduction of cell therapies could cut government healthcare costs significantly while improving care – offering accessible, safe and effective treatments.
“The world is aging dramatically,” Yanay said. “We’ve doubled life expectancy in past 150 years and we need new technologies.”
http://www.jpost.com/Diplomatic-Conference/A-biological-solution-to-the-Iranian-threat-490067
"PLX-Cells May Extend The Human Lifespan To 120,150, possibly even 200 years"
FDApproved
Sunday, 05/07/17 04:39:34 PM
Re: None
0
Post # of 18686
YouTube Video In Which Yaky Yanay Says....
That PLX-Cells May Extend The Human Lifespan To 120,150, possibly even 200 years. The video is in Hebrew, Which I Do Not Speak. However, At The 12 Second Mark, The Subtitle Clearly Shows 120,150 And 200. I Had A Friend Who Speaks Hebrew And He Confirmed What He Was Saying And Was Completely Blown-Away !
PLX-Cells May Be The Key To Extending Human Longevity In A Big Way ? Remember, Yaky Spoke 3 Times About Aging And Human Longevity In His Bioinformant Interview From March 29,2017
"We have the capacity to make 150,000 doses of commercial grade PLX cells at this time..."
FDApproved
Saturday, 05/06/17 08:05:08 PM
Re: None
0
Post # of 18685
Scaling-Up PLX-Cell Production Will Not Be An Issue For Pluristem
Excerpt From An Interview With Yaky Yanay Last November 29th
"Commercial manufacturing is a critical bottleneck in the space. Many people are now focused on this challenge, because if new technology is needed to produce commercial quantities of cells, one runs the risk of changing the cell characteristics by growing them with different technology. In contrast with others in our space, we have our own FDA and EU-approved manufacturing facility through commercialization meaning if and when our products reach approval, we are already cleared to use our own manufacturing facilities to commercialize them. We have the capacity to make 150,000 doses of commercial grade PLX cells at this time, and to increase capacity we need only scale out with additional bioreactors. We do not need to modify the patented production technology. We can make 20,000 doses from a single placenta, and this efficiency is because of our patented manufacturing technology and our placental cell source."
https://marketexclusive.com/exclusive-interview-pluristem-therapeutics-inc-nasdaqpsti-president-yaky-yanay/41188/
FDApproved
Saturday, 05/06/17 08:05:08 PM
Re: None
0
Post # of 18685
Scaling-Up PLX-Cell Production Will Not Be An Issue For Pluristem
Excerpt From An Interview With Yaky Yanay Last November 29th
"Commercial manufacturing is a critical bottleneck in the space. Many people are now focused on this challenge, because if new technology is needed to produce commercial quantities of cells, one runs the risk of changing the cell characteristics by growing them with different technology. In contrast with others in our space, we have our own FDA and EU-approved manufacturing facility through commercialization meaning if and when our products reach approval, we are already cleared to use our own manufacturing facilities to commercialize them. We have the capacity to make 150,000 doses of commercial grade PLX cells at this time, and to increase capacity we need only scale out with additional bioreactors. We do not need to modify the patented production technology. We can make 20,000 doses from a single placenta, and this efficiency is because of our patented manufacturing technology and our placental cell source."
https://marketexclusive.com/exclusive-interview-pluristem-therapeutics-inc-nasdaqpsti-president-yaky-yanay/41188/
FDApproved
Saturday, 05/06/17 08:05:08 PM
Re: None
0
Post # of 18685
Scaling-Up PLX-Cell Production Will Not Be An Issue For Pluristem
Excerpt From An Interview With Yaky Yanay Last November 29th
"Commercial manufacturing is a critical bottleneck in the space. Many people are now focused on this challenge, because if new technology is needed to produce commercial quantities of cells, one runs the risk of changing the cell characteristics by growing them with different technology. In contrast with others in our space, we have our own FDA and EU-approved manufacturing facility through commercialization meaning if and when our products reach approval, we are already cleared to use our own manufacturing facilities to commercialize them. We have the capacity to make 150,000 doses of commercial grade PLX cells at this time, and to increase capacity we need only scale out with additional bioreactors. We do not need to modify the patented production technology. We can make 20,000 doses from a single placenta, and this efficiency is because of our patented manufacturing technology and our placental cell source."
https://marketexclusive.com/exclusive-interview-pluristem-therapeutics-inc-nasdaqpsti-president-yaky-yanay/41188/
This Is Allo On The Investor Hub Board !
FDApproved
Saturday, 05/06/17 12:33:30 PM
Re: None
0
Post # of 18684
This Is Allo On The Investor Hub Board !
Great Find Blue ! I Have Been Trying To Post Some Items Since Yesterday Afternoon ! The " Controller" Has Shut Down The PSTI Yahoo Message Board. It's The Only Board Affected On Yahoo ! All Other Boards Are Working ! Wow, They Will Stop At Nothing To Silence The Truth ! We Must Be Very Close To A Mega Deal ?
I Agree It Appears We Are At A MAJOR TURNING POINT IN THE HISTORY OF PLURISTEM ! Everything Seems To Be Coming Together All At Once ! Check This FDA POST OUT FROM LAST NIGHT ! The FDA Just Approved a Drug For ALS That Was Just Approved In Japan After Just One 6 Month Clinical Trial With Good Data ! That Speaks Volumes As To How A Drug With Good Data Can Now Be Approved For A Major Unmet Need With No Treatment Options ! Pluristem Fits That Bill Perfectly ! We May Have Our First Approval By The End Of This Year ? ~ Allo~
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm557102.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
Get ready for TBT!!
Throw back Tuesday...
FDApproved
Monday, 05/08/17 01:08:05 PM
Re: None
0
Post # of 18683
Pluristem Has Contracted With Cryoport For Their Cold-Chain Distribution Of PLX-Cells.
Cryoport, Inc. @cryoport
Twitter Posted: ?5?/?8?/?2017? ?12?:?30?:?05? ?PM
Our client: $PSTI announced promising results of its NHP pilot study for PLX-R18
http://www.cryoport.com/who-we-serve/biopharmaceutical
you see... Only alopecia is able to read the mind of and speak with the 'controller' to know their inner thoughts and desires.
Can you imagine where the sp would be today if, for years, the controller hadn't suppressed the sp?
$200, $399/sh
'Over years', I would imagine this has been an expensive process for said controller...
Also, when the 'controller' emerges as a large pharma, will they be investigated / negative PR for using mysterious 'dark pools'?
Oh, and how many shares and at what price did the controller purchase their stash of SP hammering shares??
You're a terrible investor like the rest of us. You bought at the wrong time and you are losing money on paper. Your money would have been better served doing something, anything else.
Had you been a smart investor, you'd still be on the sidelines watching, waiting for that turn northwards without return, buying with both hands.
And your are right, psti is the dog being sold to cover profits from better investments.
I concur. Perhaps allo. Should seek employment with psti, replacing Dr. Klein house, so the PR/IR department can get up to speed.
As we close-out NO!vember, We can look forward to a non-event DEADcember!!
They Are Definitely Going It Alone
GEEEEEEZUs, make up your mind.
NOpe! Swing and a miss... WHERE WAS Dr. Kleinhouse getting the PR for PSTI?!?!?!
Or, one of our 2 CEO's... Very busy I'm sure.
"agonizing"... oh, the thought of it all.
- still has to be accepted by fda...
"...an oral drug designed to throw a monkey wrench into the biology driving the hedgehog pathway in acute myeloid leukemia."
Apples and Oranges, allo. We don't have an indication in-play that is ANYWHERE close to the severity and urgency of AML.
Not even close. When we have a drug that DOUBLES SURVIVAL, we can talk.
Right now, we can't even double WALKING DISTANCE much less, survival.
Our Leadership can't even get 'The CURE' for Radiation Poisoning approved, much less, approved early.
Let's get some Leadership that's been in the battle before and stop the silliness....
These institutions and the 6 ( that's 6) brokerage houses who have BUY recs out there, are just not doing their homework; all of them; right?. LMAO!
Exactly. You are learning, Grasshopper!
Ask yourself, have these 6 'brokerages' ever invested in biopharma/failures? Or have they been 100% right?!?!?!?!!! Think about it.
GIDDY-UP !
Nothing But Net!
NO!vember!
Better check again. Institutional ownership at 5.2%
I did... You were wrong, again.
Institutional Ownership
05.08%
https://www.nasdaq.com/symbol/psti/institutional-holdings
Still WELL below peer and industry average!
THUS, there are others that these 'professionals' view as BETTER options.
Professionally speaking, of course.
I guess you didn't read the link you posted.
And still WELL below 'peers' % of institutional ownership - only now at 4.5%... Industry average is 7-8%.
NOT a good sign. Once bitten, twice shy.
Pluristem to move forward with the clinical development of the program and seek other licensing partners.
https://globenewswire.com/news-release/2015/12/08/793824/0/en/Pluristem-and-United-Therapeutics-End-Licensing-Agreement-Report-Positive-Data-in-Pulmonary-Arterial-Hypertension.html
Pluristem has a long history of ethically questionable reporting to investors.
https://seekingalpha.com/article/2875876-pluristem-therapeutics-questionable-ethics-and-bucket-shop-coverage
Mesoblast May Have an Edge on Pluristem
Mesoblast could see superior results in umbilical-cord-blood transplantation in cancer patients.
https://www.barrons.com/amp/articles/mesoblast-may-have-an-edge-on-pluristem-1483045768
Renaissance Technologies LLC Lowers Position in Pluristem Therapeutics Inc. (NASDAQ:PSTI)
https://pressoracle.com/2018/11/06/pluristem-therapeutics-inc-psti-shares-sold-by-renaissance-technologies-llc.html
Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
https://reagentsglobalmarket.com/2018/11/08/latest-trend-pluristem-therapeutics-nasdaq-psti/
Report: Exploring Fundamental Drivers Behind Pluristem Therapeutics, RXi Pharmaceuticals, Saga Communications, Global Self Storage, Sequential Brands Group, and Finjan — New Horizons, Emerging Trends, and Upcoming Developments
GlobeNewswire•November 19, 2018
https://finance.yahoo.com/news/report-exploring-fundamental-drivers-behind-131500236.html
Don't recommend anyone (except you fda) hold their breath for that announcement here... Besides, why would you sit on that type of information unless you were trying to manipulate the SP... \
Maybe THAT is what yaki meant by 'managing the share price'
Great work.
Fact is... Every time I do DD on your posts, they are often found to be twisted interpretations, innuendo & hyper-leaps to the theoretical but not the practical.
The same is true here. Again.
FDApproved
Monday, 11/19/18 09:49:17 PM
Re: None
0
Post # of 18563
If You Did Some DD For Once, You Would Know It's For The DoD ! Do You Even Know Who That Is ? Wow !